Amikacin Dosing for a 65-Year-Old, 60 kg Male with Creatinine 1.8 mg/dL
For this patient with renal impairment (creatinine 1.8 mg/dL), administer amikacin 450 mg (7.5 mg/kg) as a loading dose, then adjust the dosing interval to every 48-72 hours based on therapeutic drug monitoring, rather than reducing the individual dose.
Rationale for Dosing Approach
Initial Loading Dose Calculation
The FDA label and multiple guidelines consistently recommend maintaining the full mg/kg dose even in renal impairment 1. For this 60 kg patient:
- Loading dose: 7.5 mg/kg = 450 mg (standard dose for renal impairment)
- Alternative calculation: 15 mg/kg divided by serum creatinine (15 × 60 / 1.8 = 500 mg) 1
The loading dose should not be reduced because amikacin exhibits concentration-dependent bactericidal activity, and smaller doses may reduce efficacy 2.
Estimating Renal Function
For a 65-year-old, 60 kg male with creatinine 1.8 mg/dL, the estimated creatinine clearance using Cockcroft-Gault is approximately:
- CrCl ≈ 30-35 mL/min (assuming height ~170 cm)
This places the patient in the moderate-to-severe renal impairment category (CrCl < 50 mL/min).
Dosing Interval Adjustment Strategy
The critical principle: Extend the dosing interval, not reduce the dose 3, 2.
Recommended Approach:
Initial dosing interval: Every 48-72 hours based on CrCl 30-35 mL/min 3, 2
Alternative calculation method (FDA label): Multiply serum creatinine by 9 to determine interval in hours 1
- 1.8 × 9 = 16.2 hours (round to q18-24h for practical dosing)
For intermittent dosing (2-3 times weekly): Use 12-15 mg/kg per dose 3, 2
- This would be 720-900 mg every 2-3 days
Therapeutic Drug Monitoring Requirements
Mandatory monitoring is essential given the patient's age (>59 years) and renal impairment 4, 2, 1:
Target Levels:
Sampling Strategy:
- First peak level: 60-120 minutes after infusion ends 4
- Trough level: Just before next dose
- Frequency: Weekly for first 4 weeks, then every 2 weeks if stable 4
Critical Safety Considerations
Age-Related Adjustments
For patients >59 years, the ATS/CDC/IDSA guideline specifically recommends reducing the daily dose to 10 mg/kg/day (maximum 750 mg) 2. However, this applies to daily dosing regimens. With extended interval dosing (q48-72h), the full 12-15 mg/kg per dose is maintained 2.
Toxicity Monitoring
Given this patient's risk factors (age 65, renal impairment):
Renal function monitoring 4:
- Twice weekly during month 1
- Weekly during month 2
- Fortnightly thereafter
- Increase frequency if creatinine rises
- Baseline audiogram and vestibular testing
- Monthly assessment for auditory/vestibular symptoms
- Repeat audiogram if symptoms develop
- Risk increases with age >60 years and cumulative dose >100-120 g 2
Practical Dosing Algorithm
Step 1: Administer loading dose of 450 mg IV over 30-60 minutes
Step 2: Measure peak (1-2 hours post-infusion) and trough (before next dose)
Step 3: Based on levels, adjust interval:
- If trough >5 mg/L: Extend interval to q72h or longer
- If trough <2.5 mg/L and peak adequate: Continue q48h
- If peak subtherapeutic: Consider increasing dose to 12-15 mg/kg (720-900 mg) with extended interval
Step 4: Repeat TDM weekly initially, adjusting as needed
Important Caveats
- Do not use when dialysis is being performed without specific adjustment 2, 1
- The patient's actual body weight (60 kg) is appropriate for dosing; no obesity adjustment needed 4, 5
- Duration should be limited to 7-10 days when feasible; if >10 days required, intensify monitoring 1
- Consider that elderly patients may have gastroparesis or other conditions affecting absorption if oral medications are co-administered 2
This approach prioritizes both efficacy (maintaining concentration-dependent killing) and safety (minimizing accumulation and toxicity) in this high-risk elderly patient with renal impairment.